Clinical Science

Our philosophical approach to working with the medical community to conduct clinical trials is built on evidence-based medicine. We believe in playing a leadership role by collecting solid data that helps inform decision-making. With this conviction, we have set a standard of quality and scientific rigor that is unmatched in our field.

The data must be relevant, complete and shared openly with clinicians. We must work with clinicians to design the most objective, thorough, rigorous and controlled trials possible. And we must be willing to stand by the unvarnished results.

We've invested significantly to establish preclinical and clinical trials as a highly successful and respected core competency at Boston Scientific, and we will continue to work collaboratively with internal and external colleagues to improve the quality of life for patients.

Clinical Fast Facts

• There are currently more than 600 employees in our clinical sciences organization
• Approximately 75 active or planned clinical studies
• More than 50,000 patients enrolled in drug-eluting stent clinical trials
• More than 80% of U.S. ICD or CRT-D patients first indicated for therapy by a landmark Boston Scientific-sponsored clinical trial

Boston Scientific’s Clinical Sciences organization is structured into seven functional groups.